Skip to main content
Clinical Trials/DRKS00027050
DRKS00027050
Completed
Not Applicable

The influence of the gut microbiome on immunity mediated by COVID-19 vaccination

Institut für Prävention und Tumorepidemiologie0 sites143 target enrollmentNovember 11, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
healthy volunteers
Sponsor
Institut für Prävention und Tumorepidemiologie
Enrollment
143
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 11, 2021
End Date
November 7, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Institut für Prävention und Tumorepidemiologie

Eligibility Criteria

Inclusion Criteria

  • plannend COVID\-19 vaccination with BioNTech/Pfizer; Interval between first and second vaccination exactly 3 or 6 weeks (\+/\- 1 day); age from 18 years

Exclusion Criteria

  • antibiotic intake \= 3 months before the start of the study; severe chronic illness; previous COVID\-19 illness

Outcomes

Primary Outcomes

Not specified

Similar Trials